Correlation Between Changjiang Publishing and Maccura Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Changjiang Publishing and Maccura Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Changjiang Publishing and Maccura Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Changjiang Publishing Media and Maccura Biotechnology Co, you can compare the effects of market volatilities on Changjiang Publishing and Maccura Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Changjiang Publishing with a short position of Maccura Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Changjiang Publishing and Maccura Biotechnology.

Diversification Opportunities for Changjiang Publishing and Maccura Biotechnology

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Changjiang and Maccura is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Changjiang Publishing Media and Maccura Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maccura Biotechnology and Changjiang Publishing is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Changjiang Publishing Media are associated (or correlated) with Maccura Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maccura Biotechnology has no effect on the direction of Changjiang Publishing i.e., Changjiang Publishing and Maccura Biotechnology go up and down completely randomly.

Pair Corralation between Changjiang Publishing and Maccura Biotechnology

Assuming the 90 days trading horizon Changjiang Publishing Media is expected to generate 1.19 times more return on investment than Maccura Biotechnology. However, Changjiang Publishing is 1.19 times more volatile than Maccura Biotechnology Co. It trades about 0.06 of its potential returns per unit of risk. Maccura Biotechnology Co is currently generating about -0.02 per unit of risk. If you would invest  543.00  in Changjiang Publishing Media on October 4, 2024 and sell it today you would earn a total of  414.00  from holding Changjiang Publishing Media or generate 76.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Changjiang Publishing Media  vs.  Maccura Biotechnology Co

 Performance 
       Timeline  
Changjiang Publishing 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Changjiang Publishing Media are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Changjiang Publishing is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Maccura Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Maccura Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Changjiang Publishing and Maccura Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Changjiang Publishing and Maccura Biotechnology

The main advantage of trading using opposite Changjiang Publishing and Maccura Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Changjiang Publishing position performs unexpectedly, Maccura Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maccura Biotechnology will offset losses from the drop in Maccura Biotechnology's long position.
The idea behind Changjiang Publishing Media and Maccura Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk